Extrahepatic Bile Duct Cancer
2 competing products in clinical development for Extrahepatic Bile Duct Cancer.
Pipeline by Phase
Phase 21
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| cisplatin + gemcitabine hydrochloride | Eli Lilly | Phase 3 | Completed | 40 |
| exatecan mesylate | Daiichi Sankyo | Phase 2 | Completed | 35 |